Firat Kaya

1.4k total citations
30 papers, 947 citations indexed

About

Firat Kaya is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Firat Kaya has authored 30 papers receiving a total of 947 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Infectious Diseases, 15 papers in Epidemiology and 6 papers in Surgery. Recurrent topics in Firat Kaya's work include Tuberculosis Research and Epidemiology (21 papers), Mycobacterium research and diagnosis (11 papers) and Antibiotic Resistance in Bacteria (5 papers). Firat Kaya is often cited by papers focused on Tuberculosis Research and Epidemiology (21 papers), Mycobacterium research and diagnosis (11 papers) and Antibiotic Resistance in Bacteria (5 papers). Firat Kaya collaborates with scholars based in United States, South Africa and United Kingdom. Firat Kaya's co-authors include Véronique Dartois, Jansy P. Sarathy, Matthew Zimmerman, Paul E. O’Brien, Brendan Prideaux, Pei‐Yu Chen, Clifton E. Barry, Laura E. Via, Martin Gengenbacher and Thomas Dick and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Analytical Chemistry.

In The Last Decade

Firat Kaya

26 papers receiving 936 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Firat Kaya United States	15	688	471	367	168	74	30	947
Landry Blanc United States	18	606 0.9×	470 1.0×	358 1.0×	120 0.7×	92 1.2×	27	1.0k
Jansy P. Sarathy United States	20	1.2k 1.7×	810 1.7×	541 1.5×	232 1.4×	200 2.7×	38	1.5k
Anita G. Amin United States	15	542 0.8×	463 1.0×	428 1.2×	145 0.9×	98 1.3×	29	959
Dominique J. Wiener United States	15	1.1k 1.5×	697 1.5×	470 1.3×	280 1.7×	168 2.3×	20	1.5k
Sang Nae Cho South Korea	15	1.1k 1.6×	828 1.8×	405 1.1×	359 2.1×	135 1.8×	28	1.4k
Ashima Bhaskar India	19	479 0.7×	356 0.8×	440 1.2×	60 0.4×	130 1.8×	41	982
Seok Yong Eum United States	5	714 1.0×	533 1.1×	285 0.8×	212 1.3×	87 1.2×	5	1.0k
Radhika Gupta India	15	565 0.8×	474 1.0×	605 1.6×	94 0.6×	177 2.4×	38	1.2k
Hidetsugu Tsubouchi Japan	15	617 0.9×	463 1.0×	458 1.2×	137 0.8×	66 0.9×	34	1.3k
Veronica Gruppo United States	18	989 1.4×	723 1.5×	582 1.6×	184 1.1×	138 1.9×	19	1.4k

Countries citing papers authored by Firat Kaya

Since Specialization

Citations

This map shows the geographic impact of Firat Kaya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Firat Kaya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Firat Kaya more than expected).

Fields of papers citing papers by Firat Kaya

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Firat Kaya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Firat Kaya. The network helps show where Firat Kaya may publish in the future.

Co-authorship network of co-authors of Firat Kaya

This figure shows the co-authorship network connecting the top 25 collaborators of Firat Kaya. A scholar is included among the top collaborators of Firat Kaya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Firat Kaya. Firat Kaya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bustion, Annamarie E., Firat Kaya, Jansy P. Sarathy, et al.. (2025). The Kinetics of Bedaquiline Diffusion in Tuberculous Cavities Open a Window for the Emergence of Resistance. The Journal of Infectious Diseases. 232(3). e431–e441.

Soni, Heena, Sandeep Tyagi, Firat Kaya, et al.. (2025). The KasA inhibitor JSF-3285 improves the sterilizing activity of bedaquiline-pretomanid-containing regimens in a mouse model of tuberculosis. Antimicrobial Agents and Chemotherapy. 69(6). e0013025–e0013025.

Wasserman, Sean, Maureen Dougher, Firat Kaya, et al.. (2024). Rifabutin central nervous system concentrations in a rabbit model of tuberculous meningitis. Antimicrobial Agents and Chemotherapy. 68(8). e0078324–e0078324.

Datta, Meenal, Laura E. Via, Véronique Dartois, et al.. (2024). Normalizing granuloma vasculature and matrix improves drug delivery and reduces bacterial burden in tuberculosis-infected rabbits. Proceedings of the National Academy of Sciences. 121(14). e2321336121–e2321336121. 10 indexed citations

Negatu, Dereje A., Firat Kaya, Sung Jae Shin, et al.. (2024). Durlobactam to boost the clinical utility of standard of care β-lactams against Mycobacterium abscessus lung disease. Antimicrobial Agents and Chemotherapy. 69(1). e0104624–e0104624. 2 indexed citations

Aptekmann, Ariel A., Mikhail V. Keniya, Firat Kaya, et al.. (2024). Evolutionary dynamics in gut-colonizing Candida glabrata during caspofungin therapy: Emergence of clinically important mutations in sphingolipid biosynthesis. PLoS Pathogens. 20(9). e1012521–e1012521. 3 indexed citations

Hansen, Mark, Firat Kaya, Bernard Siow, et al.. (2023). A preclinical model of TB meningitis to determine drug penetration and activity at the sites of disease. Antimicrobial Agents and Chemotherapy. 67(12). e0067123–e0067123. 2 indexed citations

Walter, Nicholas D., Allison Bauman, Karen Rossmassler, et al.. (2023). Lung microenvironments harbor Mycobacterium tuberculosis phenotypes with distinct treatment responses. Antimicrobial Agents and Chemotherapy. 67(9). e0028423–e0028423. 13 indexed citations

Kaya, Firat, et al.. (2022). Spatial quantitation of antibiotics in bone tissue compartments by laser-capture microdissection coupled with UHPLC-tandem mass spectrometry. Analytical and Bioanalytical Chemistry. 414(23). 6919–6927. 2 indexed citations

10.

Egbelowo, Oluwaseun Francis, Jansy P. Sarathy, Matthew Zimmerman, et al.. (2021). Pharmacokinetics and Target Attainment of SQ109 in Plasma and Human-Like Tuberculosis Lesions in Rabbits. Antimicrobial Agents and Chemotherapy. 65(9). e0002421–e0002421. 17 indexed citations

11.

Robertson, Gregory T., Lisa M. Massoudi, Claire L. Carter, et al.. (2021). Comparative Analysis of Pharmacodynamics in the C3HeB/FeJ Mouse Tuberculosis Model for DprE1 Inhibitors TBA-7371, PBTZ169, and OPC-167832. Antimicrobial Agents and Chemotherapy. 65(11). e0058321–e0058321. 44 indexed citations

12.

Wang, Ning, Jansy P. Sarathy, Matthew Zimmerman, et al.. (2021). On-Slide Heat Sterilization Enables Mass Spectrometry Imaging of Tissue Infected with High-Threat Pathogens Outside of Biocontainment: A Study Directed at Mycobacterium tuberculosis. Journal of the American Society for Mass Spectrometry. 32(11). 2664–2674. 4 indexed citations

13.

Sarathy, Jansy P., Ning Wang, Firat Kaya, et al.. (2021). Lesion Penetration and Activity Limit the Utility of Second-Line Injectable Agents in Pulmonary Tuberculosis. Antimicrobial Agents and Chemotherapy. 65(10). e0050621–e0050621. 22 indexed citations

14.

Gengenbacher, Martin, Matthew Zimmerman, Jansy P. Sarathy, et al.. (2020). Tissue Distribution of Doxycycline in Animal Models of Tuberculosis. Antimicrobial Agents and Chemotherapy. 64(5). 22 indexed citations

15.

Sarathy, Jansy P., Landry Blanc, Nadine Álvarez, et al.. (2019). Fluoroquinolone Efficacy against Tuberculosis Is Driven by Penetration into Lesions and Activity against Resident Bacterial Populations. Antimicrobial Agents and Chemotherapy. 63(5). 51 indexed citations

16.

Xu, Yitian, Lihua Wang, Matthew Zimmerman, et al.. (2018). Matrix metalloproteinase inhibitors enhance the efficacy of frontline drugs against Mycobacterium tuberculosis. PLoS Pathogens. 14(4). e1006974–e1006974. 55 indexed citations

17.

Negatu, Dereje A., Matthew Zimmerman, Firat Kaya, et al.. (2017). Whole-Cell Screen of Fragment Library Identifies Gut Microbiota Metabolite Indole Propionic Acid as Antitubercular. Antimicrobial Agents and Chemotherapy. 62(3). 56 indexed citations

18.

Zimmerman, Matthew, Jodi M. Lestner, Brendan Prideaux, et al.. (2017). Ethambutol Partitioning in Tuberculous Pulmonary Lesions Explains Its Clinical Efficacy. Antimicrobial Agents and Chemotherapy. 61(9). 58 indexed citations

19.

Gopal, Pooja, Priya Ragunathan, Jansy P. Sarathy, et al.. (2017). Pyrazinoic Acid Inhibits Mycobacterial Coenzyme A Biosynthesis by Binding to Aspartate Decarboxylase PanD. ACS Infectious Diseases. 3(11). 807–819. 52 indexed citations

20.

Prideaux, Brendan, Laura E. Via, Matthew Zimmerman, et al.. (2015). The association between sterilizing activity and drug distribution into tuberculosis lesions. Nature Medicine. 21(10). 1223–1227. 337 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact